This course is designed to teach ophthalmologists how to appropriately match presbyopia-correcting technology to the individual needs of each patient with cataracts. Faculty will provide pearls for effective conversations with today’s cataract surgery patients and discuss strategies to educate patients on refractive IOLs options. Drs. Elizabeth Yeu, Brandon Ayers, Karolinne Rocha and their staff colleagues will review new strategies for effective conversations with today’s presbyopia-correction cataract patients.
Supported by unrestricted education grants from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals.Matching Presbyopia-Correcting Technology to the Individual Cataract Patient's Needs
Learning Objectives
Upon completion of this activity, the participant should be able to: - Outline strategies to increase comfort in educating and communicating with patients about refractive IOL clinical outcomes, costs, risk and benefits, including quality of life and quality of vision considerations.
Accreditation
Jointly Provided by Evolve Medical Education and The Fundingsland Group 

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC, and The Fundingsland Group. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Evolve Medical Education, LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers: Internet Explorer 11 for Windows Edge (recent versions; Chromium-based) for Windows Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements: 4GB+ RAM
Recommended internet speed 5Mbps+
Faculty and Disclosures

Elizabeth Yeu, MD
Moderator
Virginia Eye Consultants
Medical Director, CVP Mid-Atlantic
Cornea, Cataract, External Disease and Refractive Surgery
Assistant Professor, Department of Ophthalmology
Eastern Virginia Medical School
Norfolk, Virginia
Brandon D. Ayres, MD
Cornea Service
Wills Eye Hospital
Philadelphia, PA
Karolinne M. Rocha, MD, PhD
Assistant Professor of Ophthalmology
Director, Cataract, Cornea and Refractive Surgery
Cataract & Refractive Surgery Fellowship Director
Medical University of South Carolina
Storm Eye Institute
Charleston, South CarolinaDISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.The following faculty/staff members have the following financial relationships with commercial interests:
Elizabeth Yeu, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Allergan, Avedro, Bausch + Lomb, BioTissue, Beaver Visitec, BlephEx, Bruder, Carl Zeiss Meditec, CorneaGen, Dompé, Expert Opinion, EyePoint Pharmaceuticals, Guidepoint, Johnson & Johnson Vision, Kala Pharmaceuticals, Lensar, Merck, Mynosys, Novartis, Ocular Science, Ocular Therapeutix, Ocusoft, Omeros, Oyster Point Pharma, Science Based Health, Shire, Sight Sciences, Sun Pharmaceutical Industries, Surface, Thea, Tarsus, TopCon, TearLab, and Visus Therapeutics. Grant/Research Support: Alcon Vision, BioTissue, Ocular Science, TopCon, and TearLab. Stock/Shareholder: BlephEx, CorneaGen, Melt, Ocular Science, Oyster Point Pharma, and Tarsus.
Brandon D. Ayres, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon Vision, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompé, Eyevance, Eyepoint Pharmaceuticals, Glaukos, Gore Surgical, Kala, Omeros, Microsurgical Technology, Mojo, Novartis, Sight Sciences, and TearLab. Speaker’s Bureau: Alcon Vision, Allergan, and Dompé.
Karolinne M. Rocha, MD, PhD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompé, and Johnson & Johnson Vision.
DISCLOSURE POLICY It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity. The following faculty/staff members have the following financial relationships with commercial interests:Elizabeth Yeu, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Avedro, Bausch + Lomb, BioTissue, Beaver Visitec, BlephEx, Bruder, Carl Zeiss Meditec, CorneaGen, Dompe, Expert Opinion, EyePoint Pharmaceuticals, Guidepoint, Johnson & Johnson Vision, Kala Pharmaceuticals, LENSAR, Melt, Merck, Mynosys, Novartis, Ocular Science, Ocular Therapeutix, Ocusoft, Omeros, Oyster Point Pharmaceuticals, Science Based Health, Shire, Sight Sciences, Sun, Surface, Thea, Tarsus, TopCon, TearLab Corporation, and Visus Therapeutix. Grant/Research Support: Alcon, BioTissue, Ocular Science, TopCon, and TearLab Corporation. Stock/Shareholder: BlephEx, CorneaGen, Melt, Ocular Science, Oyster Point Pharmaceuticals, and Tarsus. Brandon D. Ayres, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Bausch + Lomb, Dompe, Eyevance, EyePoint, Glaukos, Gore Surgical, Kala, Omeros, Microsurgical Technologies, Mojo, Novartis, and Sight Sciences. Speaker's Bureau: Alcon, Allergan, and Dompe. Karolinne M. Rocha, MD, PhD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Bausch + Lomb, Dompe, and Johnson & Johnson Vision. The Evolve Medical Education and The Fundingsland Group staff and planners have no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.Disclaimer
OFF-LABEL STATEMENT This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. DISCLAIMER The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, or Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!





























































